Azitra (AZTR) Preferred Dividend Payments (2022 - 2023)

Azitra (AZTR) posted Preferred Dividend Payments of $643267.0 for Q2 2023, down 9.66% on a QoQ basis from $712080.0 in Q1 2023, and down 7.08% year-over-year from $692246.0 in Q2 2022.

Azitra (AZTR) Preferred Dividend Payments (2022 - 2023) Analysis & Trends

Azitra's Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $643267.0 for Q2 2023.

  • Quarterly Preferred Dividend Payments fell 7.08% year-over-year to $643267.0 in Q2 2023, while the trailing twelve-month figure through Mar 2024 was $643267.0 (down 76.93% YoY) and the FY2023 annual result came in at $1.4 million, down 51.05% from the prior year.
  • Preferred Dividend Payments was $643267.0 for Q2 2023 at Azitra, down from $712080.0 in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $712080.0 in Q1 2023 and bottomed at $643267.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Nanobiotix 1,792.52 Bn 1,792.46 Bn - -
2 Akari Therapeutics 999.95 Bn 999.95 Bn - -
3 BeOne Medicines 475.97 Bn 471.17 Bn 1.35 Bn -
4 Vertex Pharmaceuticals 124.91 Bn 117.66 Bn 2.59 Bn -
5 Regeneron Pharmaceuticals 72.31 Bn 63.56 Bn 3.31 Bn -
6 Belite Bio 62.01 Bn 62.01 Bn - -
7 Argenx Se 54.23 Bn 49.04 Bn 1.41 Bn -
8 Alnylam Pharmaceuticals 38.31 Bn 35.30 Bn 959.66 Mn -
9 Revolution Medicines 36.16 Bn 36.16 Bn - -
10 Azitra 2.05 Mn 2.05 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 643,267.00
Mar 31, 2023 712,080.00
Dec 31, 2022 692,247.00
Sep 30, 2022 692,246.00
Jun 30, 2022 692,246.00